Velocity11 designed this new BioCel configuration to dispense cells into microplates and perform a series of alternating incubations and reagent additions
Velocity11 has announced a new configuration of its BioCel sample-processing platform configured to automate cell-based Elisa procedures.
The handling of cells in automated systems requires smooth and reliable operation and specialised equipment.
Velocity11 designed this new BioCel configuration to dispense cells into microplates and perform a series of alternating incubations and reagent additions.
Automated control of intermediate plate batches, cell medium removal and absorbance detection is also part of the process.
The BioCel system is said to be ideally suited to this complex assay format due to its powerful dynamic scheduling software, flexible liquid handling options and the ability to simply integrate third-party instruments.
Integrating a VPrep pipetting station, a plate washer, CO2 incubator and microplate absorbance reader the BioCel system can use VWorks software and scheduler to provide unattended automation of approximately 500 plates per run in a three-day experiment.
Cells can be plated and stored at a rate of one minute/plate.
The BioCel is one of the most compact and rapid automated sample processing systems on the market, says Velocity11.
BioCel is capable of automating a wide range of applications, spanning from compound plate replication and HTS assays in drug discovery research to nucleic acid sample preparation in genomics laboratories.
Velocity11, is privately held and focused on pioneering automation technology solutions for life science laboratories.
The company's customers include most of the major pharmaceutical and biotechnology companies as well as leading genome centres and academic institutions.
